Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Transdermally absorbed preparation of anti-dementia drug

A preparation and drug technology, applied in the field of percutaneous absorption preparations

Inactive Publication Date: 2014-07-23
TEIKOKU SEIYAKU KK TEIKOKU SEIYAKU CO LTD
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0014]However, when the administration period of the anti-dementia drug is set to about one week, the sticking area of ​​the preparation increases with the increase of the drug amount , the attachment position is limited, and the use of percutaneous absorption preparations often becomes difficult on the patient side

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Transdermally absorbed preparation of anti-dementia drug
  • Transdermally absorbed preparation of anti-dementia drug
  • Transdermally absorbed preparation of anti-dementia drug

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0092] [Table 1]

[0093]

[0094] The above plaster solution was coated on a polyethylene terephthalate liner, and dried at 70° C. for 15 minutes to obtain a drug-containing layer. Adjusted so that the amount of the dried drug-containing layer is 100 g / m 2 .

[0095] Then, the upper support layer (Scotchpak (商标) 9732, manufactured by 3M). Thereafter, the liner was peeled off from the drug-containing layer to obtain a laminate.

[0096] Fixture setting

[0097] Duro-Tak (商标) 87-2287 (manufactured by National Starch & Chemical) was coated on a polyethylene terephthalate liner, and dried at 80° C. for 15 minutes to obtain an adhesive layer. Make the quality of the adhesive layer after drying be 100g / m 2 . Then, an upper covering layer (polyester fabric) was laminated on one side of the adhesive layer opposite to the liner to obtain a fixing mechanism.

[0098] Next, the liner on the adhesive layer of the fixing means was peeled off, and the support layer of the pr...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to a transdermal preparation capable of stably administering an anti-dementia drug for a long period of about one week. More specifically, the present invention relates to a transdermal absorption preparation of an anti-dementia drug comprising a drug-containing layer containing an anti-dementia therapeutic drug, a polymer compound having an amino group, and a polyhydric alcohol fatty acid ester , polyols, polycarboxylates and styrenic polymers.

Description

[0001] References to related applications [0002] This patent application claims priority based on Japanese Patent Application No. 2009-285466 filed on December 16, 2009, and the entire disclosure content of said prior patent application is incorporated as a part of the disclosure of this specification. technical field [0003] The present invention relates to a transdermal absorption preparation capable of long-term and stable administration of anti-dementia drugs. Background technique [0004] In recent years, with the increase of elderly people, the number of patients with dementia such as Alzheimer's disease has also increased, and the care of patients has become a social issue. On the other hand, the development of anti-dementia drugs is also rapidly progressing. For example, donepezil hydrochloride is widely used as a therapeutic agent for Alzheimer's disease having an acetylcholinesterase inhibitory effect. In the past, these anti-dementia drugs were mostly admin...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/70A61K31/13A61K31/27A61K31/445A61K31/473A61K31/55A61K47/10A61K47/14A61K47/32A61P25/28
CPCA61K47/14A61K47/26A61K9/7084A61K31/473A61K47/32A61K31/445A61K31/55A61K31/27A61K31/13A61K9/7053A61P25/28A61K9/70
Inventor 伊东健
Owner TEIKOKU SEIYAKU KK TEIKOKU SEIYAKU CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products